Vice President, Projects MASH/NASH
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Bagsværd
Are you an ambitious leader seeking a new challenge in the pharmaceutical industry? Are you driven by the idea of improving the lives of millions who suffer from MASH/NASH? (MASH: Metabolic dysfunction-associated steatohepatitis; NASH: nonalcoholic steatohepatitis). If yes, then we have the perfect commercial opportunity for you as Vice President, Project MASH The Position Preferably based in Copenhagen, Denmark, you will report to the Senior Vice President, Other Serious Chronic Diseases franchise (OSCD). You will be responsible for providing strategic commercial leadership for current and future phase 2 products in the MASH therapy area. You will also be accountable for portfolio strategies, commercial claims & deliverables for high value phase 3 commercial projects with substantial growth potential identified in the current long range forecasts. Key Responsibilities The project portfolio under this Vice President will drive a substantial share of Novo Noridisk’s growth short and long-term and have the following strategic priorities: Develop the commercial label strategy for sema MASH launch, working as the commercial representative in the Global Project Team. Develop aspirational commercial target product profiles to guide development projects with the objective to maximize project potential in well-defined patient and HCP segments. Develop the pipeline projects (post phase 2) including FGF21 lead and life cycle management indications in accordance with MASH Therapy Area strategy and the Commercial MASH Portfolio strategy. Contribute to the development/update of MASH Business Plans and lead specific or identified commercial contributions to Therapy Area Strategies (TAS) for MASH. Potential identified biomarkers and external diagnostic assessments and develop value generation proposals. Lead and develop team with focus on strong performance and high level of engagement, in alignment with the Novo Nordisk Way. As Vice President, you will provide strong strategic leadership in a highly complex, rapidly evolving disease area requiring alignment with multiple stakeholders across EVP areas and ensuring robust, clear prioritisation in an uncertain market environment and be prepared to make difficult choices and trade-offs. Qualifications
To thrive and succeed in this role, we expect you to have a master’s degree in business or science, as well as more than 10 years of pharmaceutical industry experience, preferably across the value chain: early product development, analytics, lifecycle management, commercial strategy (both short and long-term), affiliate execution including P&L understanding. Moreover, you need to have experience entering new therapy areas, good alliance, and partnership management skills. A deep understanding of product/drug development and commercialization including, market development, regulatory, product supply, market access, financial management, clinical/medical. Experience linking commercial strategies to execution within product launch planning and execution and experience working with R&D, marketing, pharmaceutical products, or medical devices with international exposure in a large organization are also indispensable for this position. Other requirements include solid leadership experience – delivering proven results through a high performing team, strong capacity for work and managing multiple projects, delivering high quality on time, very strong results-orientation, and an ability to successfully navigate and comply with relevant Novo Nordisk policies and SOPs. If you additionally have a high energy level, curiosity, ambition for self and for the brand, good communication and presentation skills, flexibility and open and honest communication, great stakeholder management capabilities and excellent strategic and analytical skills as well as verbal, communication, facilitation, and presentation skills, and finally, fluency in written and spoken English, then this is the position for you.
About the Department The Other Serious Chronic Diseases Commercial Franchise is located in Søborg, Denmark, and focuses on Cardiovascular Disease, MASH, Chronic Kidney and Early Alzheimer’s Disease therapeutic areas. OSCD is a growing area within Novo Nordisk. At present, we have a phase 3 trial ongoing investigating Semaglutide for treatment of MASH. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.
Contact
For further information, please contact Senior Executive Search Partner, Anette Schmidt Jepsen at [email protected] . If you believe that you are qualified and willing to take the challenge, please send your CV and relevant documentation directly via our online application tool.
Deadline
Please submit your application via our online application tool by 4th Dec 2023.
To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
To thrive and succeed in this role, we expect you to have a master’s degree in business or science, as well as more than 10 years of pharmaceutical industry experience, preferably across the value chain: early product development, analytics, lifecycle management, commercial strategy (both short and long-term), affiliate execution including P&L understanding. Moreover, you need to have experience entering new therapy areas, good alliance, and partnership management skills. A deep understanding of product/drug development and commercialization including, market development, regulatory, product supply, market access, financial management, clinical/medical. Experience linking commercial strategies to execution within product launch planning and execution and experience working with R&D, marketing, pharmaceutical products, or medical devices with international exposure in a large organization are also indispensable for this position. Other requirements include solid leadership experience – delivering proven results through a high performing team, strong capacity for work and managing multiple projects, delivering high quality on time, very strong results-orientation, and an ability to successfully navigate and comply with relevant Novo Nordisk policies and SOPs. If you additionally have a high energy level, curiosity, ambition for self and for the brand, good communication and presentation skills, flexibility and open and honest communication, great stakeholder management capabilities and excellent strategic and analytical skills as well as verbal, communication, facilitation, and presentation skills, and finally, fluency in written and spoken English, then this is the position for you.
About the Department The Other Serious Chronic Diseases Commercial Franchise is located in Søborg, Denmark, and focuses on Cardiovascular Disease, MASH, Chronic Kidney and Early Alzheimer’s Disease therapeutic areas. OSCD is a growing area within Novo Nordisk. At present, we have a phase 3 trial ongoing investigating Semaglutide for treatment of MASH. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.
Contact
For further information, please contact Senior Executive Search Partner, Anette Schmidt Jepsen at [email protected] . If you believe that you are qualified and willing to take the challenge, please send your CV and relevant documentation directly via our online application tool.
Deadline
Please submit your application via our online application tool by 4th Dec 2023.
To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Projektleder", og befinder sig i kategorien "Ledelse og personale".
Arbejdsstedet er beliggende i Bagsværd.
Jobbet er oprettet på vores service den 20.11.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Projektleder
- Bagsværd
Lignende jobs
-
Projektleder i Søborg
Are you interested in driving high-profile strategic projects within Development and representing Development across the [xxxxx] value chain? Do you want to impact the strategic direction of..Få mere info- Projektleder
- Søborg
-
Projektleder i Søborg
Are you eager to drive financial and strategic analyses close to the center of decision-making in a global pharmaceutical company? Do you excel in analyzing financial performance metrics and transf..Få mere info- Projektleder
- Søborg
-
Projektleder i Bagsværd
Are you an experienced project manager with a passion for driving digital solutions? Do you thrive in a cross-functional and dynamic environment? Are you eager to improve and standardise processes?.Få mere info- Projektleder
- Bagsværd
-
Projektleder i Taastrup
Har du det bedst, når du selvstændigt styrer projekter i mål fra A til Z? Ser du dig selv i en serviceorienteret entreprenørvirksomhed, hvor gode relationer og kompetent faglig sparring er i højsæd..Få mere info- Projektleder
- Taastrup
Statistik over udbudte jobs som projektledere i Bagsværd
Herunder ser du udviklingen i udbudte projektleder i Bagsværd over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal projektledere.
Se flere statistikker her:
Statistik over udbudte projektledere over tid
| Dato | Alle jobs som projektledere |
|---|---|
| 19. maj 2024 | 15 |
| 18. maj 2024 | 15 |
| 17. maj 2024 | 15 |
| 16. maj 2024 | 15 |
| 15. maj 2024 | 15 |
| 14. maj 2024 | 15 |
| 13. maj 2024 | 16 |
| 12. maj 2024 | 20 |
| 11. maj 2024 | 20 |
| 10. maj 2024 | 20 |
| 9. maj 2024 | 21 |
| 8. maj 2024 | 18 |
| 7. maj 2024 | 19 |
| 6. maj 2024 | 18 |
| 5. maj 2024 | 17 |
| 4. maj 2024 | 18 |
| 3. maj 2024 | 16 |
| 2. maj 2024 | 16 |
| 1. maj 2024 | 16 |
| 30. april 2024 | 14 |
| 29. april 2024 | 14 |
| 28. april 2024 | 14 |
| 27. april 2024 | 14 |
| 26. april 2024 | 14 |
| 25. april 2024 | 12 |
| 24. april 2024 | 11 |
| 23. april 2024 | 10 |
| 22. april 2024 | 11 |
| 21. april 2024 | 11 |
| 20. april 2024 | 11 |
| 19. april 2024 | 10 |